# A Study of LY4515100 in Participants With Pain Following Third Molar Removal

> **NCT07511816** · PHASE2 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 212 (estimated)

## Conditions studied

- Acute Pain
- Molar
- Molar, Third
- Surgery, Oral

## Interventions

- **DRUG:** LY4515100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07511816
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07511816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07511816, "A Study of LY4515100 in Participants With Pain Following Third Molar Removal". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07511816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*